Traitement du covid 19 par anticorps monoclonaux Maternal #RSV vaccination and nirsevimab reduced RSV associated hospitalizations among US infants in 20242025 by up to 51%. Both interventions demonstrated high effectiveness and durability in real world surveillance. https: ja.ma 4saoasz Pharmacocintique des anticorps monoclonaux O. Le Tilly, D. Ternant, T. Bejan Angoulvant, G. Paintaud Lymph node targeted multi epitope subunit vaccine promotes effective immunity to EBV in HLA expressing mice Nature Communications With winter approaching, it's important to protect infants from RSV, which is very harmful to the very young. A safe and effective vaccine is available for pregnant women and newborns. Learn more: